Genetic Polymorphisms of GSTM1, GSTT1, and GSTP1 with Prostate Cancer Risk: A Meta-Analysis of 57 Studies

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Gong, Mancheng ^a   Dong, Wenjing ^a   Shi, Zhirong ^b   Xu, Yangyang ^c   Ni, Wenjun ^d   An, Ruihua ^a  

^a THE FIRST AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

^b ZHUHAI PEOPLE S HOSPITAL ZHUHAI HOSPITAL AFFILIATED WITH JINAN UNIVERSITY   (China)

^c HARBIN MEDICAL UNIVERSITY   (China)

^d Department of Urological Surgery   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1; GUANINE;

ARTICLE; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DNA POLYMORPHISM; ETHNICITY; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; GSTM1 GENE; GSTP1 GENE; GSTT1 GENE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS (TOPIC); NULL ALLELE; OUTCOME ASSESSMENT; PROSTATE CANCER; RISK ASSESSMENT; SYSTEMATIC REVIEW;

GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; HUMANS; MALE; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC NEOPLASMS; PUBLICATION BIAS; RISK;

EID: 84870039704     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0050587     Document Type: Article

References (89)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, et al. (2006) Cancer statistics. CA Cancer J Clin 56: 106-130.
2. Greenlee RT, Hill-Harmon MB, Murray T, Thun M, (2001) Cancer statistics. CA Cancer J Clin 51: 15-36.
3. Parkin DM, Bray F, Ferlay J, Pisani P, (2002) Global cancer statistics. CA Cancer J Clin 55: 74-108.
4. Fleshner N, Zlotta AR, (2007) Prostate cancer prevention: past, present, and future. Cancer 110: 1889-1899.
5. American Cancer Society: Cancer Facts & Figures 2009. 2009.
6. Hayes JD, Pulford DJ, (1995) The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 30: 445-600.
7. Ryberg D, Skaug V, Hewer A, Phillips DH, Harries LW, et al. (1997) Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. Carcinogenesis 18: 1285-1289.
8. Rebbeck TR, (1997) Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomarkers Prev 6: 733-743.
9. Hayes JD, Strange RC, (2000) Glutathione S-transferases polymorphisms and their biological consequence. Pharmacology 61: 154-166.
10. Hayes JD, Flanagan JU, Jowsey IR, (2005) Glutathione transferases. Annu Rev Pharmacol Toxtcol 45: 51-88.
11. Pearson WR, Vorachek WR, Xu SJ, Berger R, Hart I, et al. (1993) Identification of class-mu glutathione transferase genes GSTM1-GSTM5 on human chromosome 1p13. Am J Hum Genet 53: 220-233.
12. Webb G, Vaska V, Coggan M, Board P, (1996) Chromosomal localization of the gene for the human theta class glutathione transferase (GSTT1). Genomics 33: 121-123.
13. Norppa H, (2004) Cytogenetic biomarkers and genetic polymorphisms. Toxicol Lett 149: 309-334.
14. McIlwain CC, Townsend DM, Tew KD, (2006) Glutathione S-transferase polymorphisms: cancer incidence and therapy. Oncogene 25: 1639-1648.
15. Ali-Osman F, Akande O, Antoun G, Mao JX, Buolamwini J, (1997) Molecular cloning, characterization, and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase Pi gene variants. Evidence for differential catalytic activity of the encoded proteins. J Biol Chem. 272: 10004-10012.
16. Hu X, Ji X, Srivastava SK, Xia H, Awasthi S, et al. (1997) Mechanism of differential catalytic efficiency of two polymorphic forms of human glutathione S-transferase P1-1 in the glutathione conjugation of carcinogenic diol epoxide of chrysene. Arch Biochem Biophys 345: 32-38.
17. Sundberg K, Johansson AS, Stenberg G, Widersten M, Seidel A, et al. (1998) Differences in the catalytic efficiencies of allelic variants of glutathione transferase P1-1 towards carcinogenic diol epoxides of polycyclic aromatic hydrocarbons. Carcinogenesis 19: 433-436.
18. Mo Z, Gao Y, Cao Y, Gao F, Jian L, (2009) An updating meta-analysis of the GSTM1, GSTT1, and GSTP1 polymorphisms and prostate cancer: a HuGE review. Prostate 69: 662-688.
19. Higgins JP, Thompson SG, Deeks JJ, Altman DG, (2003) Measuring inconsistency in meta-analyses. BMJ 327: 557-560.
20. Mantel N, Haenszel W, (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719-748.
21. DerSimonian R, Laird N, (1986) Meta-analysis in clinical trials. Control Clini Trials 7: 177-188.
22. Egger M, Davey Smith G, Schneider M, Minder C, (1997) Bias in meta-analysis detected by a simple, graphical test. Br Med J 315: 629-634.
23. Murata M, Shiraishi T, Fukutome K, Watanabe M, Nagao M, et al. (1998) Cytochrome P4501A1 and glutathione S-transferase M1 genotypes as risk factors for prostate cancer in Japan. Jpn J Clin Oncol 28: 657-660.
24. Kelada SN, Kardia SL, Walker AH, Wein AJ, Malkowicz SB, et al. (2000) The glutathione S-transferase-mu and-theta genotypes in the etiology of prostate cancer: genotype-environment interactions with smoking. Cancer Epidemiol Biomarkers Prev 9: 1329-1334.
25. Guan TY, Li M, Liu SZ, Li Y, Zhou LQ, et al. (2004) CYP1A1 and GSTM1 gene polymorphisms and genetic susceptibility to prostate cancer. Chin J Urol 10: 697-700.
26. Nock NL, Bock C, Neslund-Dudas C, Beebe-Dimmer J, Rundle A, et al. (2009) Polymorphisms in glutathione S-transferase genes increase risk of prostate cancer biochemical recurrence differentially by ethnicity and disease severity. Cancer Causes Control 20: 1915-1926.
27. Murata M, Watanabe M, Yamanaka M, Kubota Y, Ito H, et al. (2001) Genetic polymorphisms in cytochrome P450 (CYP) 1A1, CYP1A2, CYP2E1, glutathione S-transferase (GST) M1 and GSTT1 and susceptibility to prostate cancer in the Japanese population. Cancer Lett 165: 171-177.
28. Rebbeck TR, Walker AH, Julie M, White DL, Wein AJ, et al. (1999) Glutathione S-Transferase-m (GSTM1) and-u (GSTT1) Genotypes in the Etiology of Prostate Cancer. Cancer Epidemiol Biomarkers Prev 8: 283-287.
29. Guan TY, Li M, Na YQ, (2005) Polymorphism of metabolic gene and genetic susceptibility to prostate cancer. Chin J Surg 43: 1467-1470.
30. Rybicki BA, Neslund-Dudas C, Nock NL, Schultz LR, Eklund L, et al. (2006) Prostate cancer risk from occupational exposure to polycyclic aromatic hydrocarbons interacting with the GSTP1 Ile105Val polymorphism. Cancer Detect Prev 30: 412-422.
31. Debes JD, Yokomizo A, McDonnell SK, Hebbring SJ, Christensen GB, et al. (2004) Gluthatione S-transferase P1 polymorphism I105V in familial and sporadic prostate cancer. Cancer Genet Cytogenet 155: 82-86.
32. Harries LW, Stubbins MJ, Forman D, Howard GC, Wolf CR, (1997) Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis 18: 641-644.
33. Wadelius M, Autrup JL, Stubbins MJ, Andersson SO, Johansson JE, et al. (1999) Polymorphisms in NAT2, CYP2D6, CYP2C19 and GSTP1 and their association with prostate cancer. Pharmacogenetics 9: 333-340.
34. Autrup JL, Thomassen LH, Olsen JH, Wolf H, Autrup H, (1999) Glutathione S-transferases as risk factors in prostate cancer. Eur J Cancer Prev 8: 525-832.
35. Steinhoff C, Franke KH, Golka K, Thier R, Romer HC, et al. (2000) Glutathione transferase isozyme genotypes in patients with prostate and bladder carcinoma. Arch Toxicol 74: 521-526.
36. Shepard TF, Platz EA, Kantoff PW, Nelson WG, Isaacs WB, et al. (2000) No association between the I105V polymorphism of the glutathione S-transferase P1 gene (GSTP1) and prostate cancer risk: A prospective study. Cancer Epidemiol Biomarkers Prev 9: 1267-1268.
37. Gsur A, Haidinger G, Hinteregger S, Bernhofer G, Schatzl G, et al. (2001) Polymorphisms of glutathione S-transferase genes (GSTP1, GSTM1 and GSTT1) and prostate-cancer risk. Int J Cancer 95: 152-155.
38. Kote-Jarai Z, Easton D, Edwards SM, Jefferies S, Durocher F, et al. (2001) Relationship between glutathione S-transferase M1, P1 and T1 polymorphisms and early onset prostate cancer. Pharmacogenetics 11: 325-330.
39. Luscombe CJ, French ME, Liu S, Saxby MF, Farrell WE, et al. (2002) Glutathione S-transferase GSTP1 genotypes are associated with response to androgen ablation therapy in advanced prostate cancer. Cancer Detect Prev 26: 376-380.
40. Beer TM, Evans AJ, Hough KM, Lowe BA, McWilliams JE, et al. (2002) Polymorphisms of GSTP1 and related genes and prostate cancer risk. Prostate Cancer and Prostatic Diseases 5: 22-27.
41. Jeronimo C, Varzim G, Henrique R, Oliveira J, BentoMJ, et al, (2002) I105V polymorphism and promoter methylation of the GSTP1 gene in prostate adenocarcinoma. Cancer Epidemiol Biomarkers Prev 11: 445-450.
42. Nakazato H, Suzuki K, Matsui H, Koike H, Okugi H, et al. (2003) Association of genetic polymorphisms of glutathione S-transferase genes (GSTM1, GSTT1 and GSTP1) with familial prostate cancer risk in a Japanese population. Anticancer Res 23: 289-902.
43. Kidd LC, Woodson K, Taylor PR, Albanes D, Virtamo J, et al. (2003) Polymorphisms in glutathione S-transferase genes (GST-M1 GST-T1 and GST-P1) and susceptibility to prostate cancer among male smokers of the ATBC cancer prevention study. Eur J Cancer Prev 12: 317-320.
44. Nam RK, Zhang WW, Trachtenberg J, Jewett MA, Emami M, et al. (2003) Comprehensive assessment of candidate genes and serological markers for the detection of prostate cancer. Cancer Epidemiol Biomarkers Prev 12: 1429-1437.
45. Acevedo C, Opazo JL, Huidobro C, Cabezas J, Iturrieta J, et al. (2003) Positive correlation between single or combined genotypes of CYP1A1 and GSTM1 in relation to prostate cancer in Chilean people. Prostate 57: 111-117.
46. Medeiros R, Vasconcelos A, Costa S, Pinto D, Ferreira P, et al. (2004) Metabolic susceptibility genes and prostate cancer risk in a southern European population: The role of glutathione S-transferases GSTM1, GSTM3, and GSTT1 genetic polymorphisms. Prostate 58: 414-420.
47. Mao GE, Morris G, Lu QY, Cao W, Reuter VE, et al. (2004) Glutathione S-transferase P1 Ile105Val polymorphism, cigarette smoking and prostate cancer. Cancer Detection and Prev 28: 368-374.
48. Joseph MA, Moysich KB, Freudenheim JL, Shields PG, Bowman ED, et al. (2004) Ambrosone cruciferous vegetables, genetic polymorphisms in glutathione S-transferases m1 and t1, and prostate cancer risk. Nutr Cancer 50: 206-213.
49. Mittal RD, Srivastava DSL, Mandhani A, Kumar A, Mittal B, (2004) PolymorphismofGSTM1 and GSTT1 genes in prostate cancer: A study from North India. Indian J Cancer 41: 115-119.
50. Aktas D, Hascicek M, Sozen S, Ozen H, Tuncbilek E, (2004) CYP1A1 and GSTM1 polymorphic genotypes in patients with prostate cancer in a Turkish population. Cancer Genet Cytogenet 154: 81-85.
51. Antognelli C, Mearini L, Talesa VN, Giannantoni A, Mearini E, (2005) Association of CYP17, GSTP1, and PON1 polymorphisms with the risk of prostate cancer. Prostate 63: 240-251.
52. Komiya Y, Tsukino H, Nakao H, Kuroda Y, Imai H, et al. (2005) Human glutathione S-transferase A1, T1, M1, and P1 polymorphisms and susceptibility to prostate cancer in the Japanese population. J Cancer Res Clin Oncol 131: 238-242.
53. Lai MT, Chen RH, Tsai FJ, Wan L, Chen WC, (2005) Glutathione S-transferaseM1 gene but not insulin-like growth factor-2 gene or epidermal growth factor gene is associated with prostate cancer. Urol Oncol 23: 225-229.
54. Caceres DD, Iturrieta J, Acevedo C, Huidobro C, Varela N, et al. (2005) Relationship among metabolizing genes, smoking and alcohol used as modifier factors on prostate cancer risk: Exploring some gene-gene and gene-environment interactions. Eur J Epidemiol 20: 79-88.
55. Srivastava DSL, Mandhani A, Mittal B, Mittal RD, (2005) Genetic polymorphism of glutathione S-transferase genes (GSTM1,GSTT1 and GSTP1) and susceptibility to prostate cancer in Northern India. 95: 170-173.
56. Vijayalakshmi K, Vettriselvi V, Krishnan M, Shroff S, Vishwa-nathan KN, et al. (2005) Polymorphisms at GSTM1 and GSTP1 gene loci and risk of prostate cancer in a South Indian population. Asian Pac J Cancer Prev 6: 309-314.
57. Yang J, Wu HF, Zhang W, Gu M, Hua LX, et al. (2006) Polymorphisms of metabolic enzyme genes, living habits and prostate cancer susceptibility. Front Biosci 11: 2052-2060.
58. Agalliu I, Langeberg WJ, Lampe JW, Salinas CA, Stanford JL, (2006) Glutathione S-transferase M1, T1, and P1 polymorphisms and prostate cancer risk in middle-aged men. Prostate 66: 146-156.
59. Quiñones LA, Irarrázabal CE, Rojas CR, Orellana CE, Acevedo C, et al. (2006) Joint effect among p53, CYP1A1, GSTM1 polymorphism combinations and smoking on prostate cancer risk: An exploratory genotype-environment interaction study. Asian J Androl 8: 349-355.
60. Silig Y, Pinarbasi H, Gunes S, Ayan S, Bagci H, et al. (2006) Polymorphisms of CYP1A1, GSTM1, GSTT1, and prostate cancer risk in Turkish population. Cancer Invest 24: 41-45.
61. Mittal RD, Mishra DK, Mandhani A, (2006) Evaluating polymorphic status of glutathione S-transferase genes in blood and tissue samples of prostate cancer patients. Asian Pacific J Cancer Prev 7: 444-446.
62. Mallick S, Romana M, Blanchet P, Multigner L, (2007) GSTM1 and GSTT1 polymorphisms and the risk of prostate cancer in a Caribbean population of African descent. Urology 69: 1165-1169.
63. Li M, Guan TY, Li Y, Na YQ, (2008) Polymorphisms of GSTM1 and CYP1A1 genes and their genetic susceptibility to prostate cancer in Chinese men. Chin Med J (Engl) 121: 305-308.
64. Ashtiani ZO, Hasheminasab SM, Ayati M, Goulian BS, Modarressi MH, (2010) Are GSTM1, GSTT1 and CAG repeat length of androgen receptor gene polymorphisms associated with risk of prostate cancer in Iranian patients? Pathol Oncol Res 17: 269-275.
65. Kumar V, Yadav CS, Datta SK, Singh S, Ahmed RS, et al. (2011) Association of GSTM1 and GSTT1 polymorphism with lipid peroxidation in benign prostate hyperplasia and prostate cancer: a pilot study. Dis Markers 30: 163-169.
66. Thakur H, Gupta L, Sobti RC, Janmeja AK, Seth A, et al. (2011) Association of GSTM1T1 genes with COPD and prostate cancer in north Indian population. Mol Biol Rep 38: 1733-1739.
67. Steinbrecher A, Rohrmann S, Timofeeva M, Risch A, Jansen E, et al. (2010) Dietary glucosinolate intake, polymorphisms in selected biotransformation enzymes, and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 19: 135-143.
68. Rodrigues IS, Kuasne H, Losi-Guembarovski R, Fuganti PE, Gregório EP, et al. (2011) Evaluation of the influence of polymorphic variants CYP1A1 2B, CYP1B1 2, CYP3A4 1B, GSTM1 0, and GSTT1 0 in prostate cancer. Urol Oncol 29: 654-663.
69. Lavender NA, Benford ML, VanCleave TT, Brock GN, Kittles RA, et al. (2009) Examination of polymorphic glutathione S-transferase (GST) genes, tobacco smoking and prostate cancer risk among men of African descent: a case-control study. BMC Cancer 9: 397.
70. Safarinejad MR, Shafiei N, Safarinejad SH, (2011) Glutathione S-transferase gene polymorphisms (GSTM1, GSTT1, GSTP1) and prostate cancer: a case-control study in Tehran, Iran. Prostate Cancer Prostatic Dis 14: 105-113.
71. Lima MM Jr, Oliveira MN, Granja F, Trindade AC, De Castro Santos LE, et al. (2008) Lack of association of GSTT1, GSTM1, GSTO1, GSTP1 and CYP1A1 polymorphisms for susceptibility and outcome in Brazilian prostate cancer patients. Folia Biol (Praha) 54: 102-108.
72. Souiden Y, Mahdouani M, Chaieb K, Elkamel R, Mahdouani K, (2010) Polymorphisms of glutathione-S-transferase M1 and T1 and prostate cancer risk in a Tunisian population. Cancer Epidemiol 34: 598-603.
73. Sivonová M, Waczulíková I, Dobrota D, Matáková T, Hatok J, et al. (2009) Polymorphisms of glutathione-S-transferase M1, T1, P1 and the risk of prostate cancer: a case-control study. J Exp Clin Cancer Res 28: 32.
74. Kwon DD, Lee JW, Han DY, Seo IY, Park SC, et al. (2011) Relationship between the Glutathione-S-Transferase P1, M1, and T1 Genotypes and Prostate Cancer Risk in Korean Subjects. Korean J Urol 52: 247-252.
75. Sahar Ansari B, Vasudevan R, Mirinargesi M, Patimah I, Sabariah AR, et al. (2009) Lack of association of glutathione S-transferase gene polymorphisms in Iranian prostate cancer subjects. Am J Biochem & Biotech 5: 30-34.
76. Wang YL, Jiang J, Wang LF, Liu YF, (2005) Polymorphisms of glutathione-S-transferase genes GSTM1 and GSTT1 and prostate cancer risk in Chinese population. Acta Academiae medicinae militaris tertiae 10: 1039-1041.
77. Xu XX, Chang WJ, Hou JG, Xu DF, Cui XG, et al. (2010) Relationship of GSTP1,RASSF1A polymorphisms and environmental agent with susceptibility to prostate cancer: a case-control study. Academic Journal of Second Military Medical University 1: 12-17.
78. Wang YL, Jiang J, Jin FS, Wang LF, Wan JH, (2008) Polymorphisms of glutathione-S-transferase gene Pi (GSTP1) and prostate cancer risk in Chinese population. Shanxi Med J 5: 410-412.
79. Hemelrijck MV, Rohrmann S, Steinbrecher A, Kaaks R, Teucher B, et al. (2012) Heterocyclic Aromatic Amine [HCA] Intake and Prostate Cancer Risk: Effect Modification by Genetic Variants. Nutr Cancer 64: 704-713.
80. Catsburg C, Joshi AD, Corral R, Lewinger JP, Koo J, et al. (2012) Polymorphisms in carcinogen metabolism enzymes, fish intake, and risk of prostate cancer. Carcinogenesis 33: 1352-1359.
81. Qadri Q, Sameer AS, Shah ZA, Hamid A, Alam S, et al. (2011) Genetic polymorphism of the glutathione-S-transferase P1 gene (GSTP1) and susceptibility to prostate cancer in the Kashmiri population. Genet Mol Res 10: 3038-3045.
82. Foley R, Hollywood D, Lawler M, (2004) Molecular pathology of prostate cancer: the key to identifying new biomarkers of disease. Endocr Relat Cancer 11: 477-488.
83. Strange RC, Spiteri MA, Ramachandran S, Fryer AA, (2001) Glutathione-S-transferase family of enzymes. Mutat Res 482: 21-26.
84. Xue H, Su J, Sun K, Xie W, Wang H, (2011) Glutathione S-transferase M1 and T1 gene polymorphism and COPD risk in smokers: an updated analysis. Mol Biol Rep 39: 5033-5042.
85. Marcos M, Pastor I, Chamorro AJ, Ciria-Abad S, González-Sarmiento R, et al. (2011) Meta-analysis: glutathione-S-transferase allelic variants are associated with alcoholic liver disease. Aliment Pharmacol Ther 34: 1159-1172.
86. Wang J, Zou L, Huang S, Lu F, Lang X, et al. (2010) Genetic polymorphisms of glutathione S-transferase genes GSTM1, GSTT1 and risk of coronary heart disease. Mutagenesis 25: 365-369.
87. Choubey VK, Sankhwar SN, Tewari R, Sankhwar P, Singh BP, et al. (2012) Null genotypes at the GSTM1 and GSTT1 genes and the risk of benign prostatic hyperplasia: A case-control study and a meta-analysis. Prostate: 1-7. Available: http://dx.doi.org/10.1002/pros.22549.
88. Zintzaras E, Ioannidis JP, (2005) Heterogeneity testing in meta-analysis of genome searches. Genet Epidemiol 28: 123-137.
89. Lin PI, Vance JM, Pericak-Vance MA, Martin ER, (2007) No gene is an island: the flip-flop phenomenon. Am J Hum Genet 80: 531-538.